<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00467857</url>
  </required_header>
  <id_info>
    <org_study_id>IS 100-06-0001</org_study_id>
    <nct_id>NCT00467857</nct_id>
  </id_info>
  <brief_title>Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination</brief_title>
  <official_title>A Randomized, Controlled, Parallel Group, Multi-center, Open Label Study Comparing Common Surgical Skin Preparation Solutions in Combination With InteguSeal Versus Common Surgical Skin Preparation Solutions to Reduce Skin Flora Contamination.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kimberly-Clark Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kimberly-Clark Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if there is a qualitative reduction in microbial
      skin flora post-surgery compared to pre-surgery when a cyanoacrylate based microbial sealant
      is used in combination with a surgical skin preparation solution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CDC states that there are two sources of surgical site infection (SSI) pathogens-
      endogenous and exogenous. The endogenous flora of the patient's skin, mucous membranes, or
      hollow viscera are the source of pathogens for most SSIs. In addition to the known sources of
      SSI pathogen, there are also known risk factors for SSI. The risk factors for SSIs may be
      patient-related, or related to the preoperative, intra-operative, and post-operative surgical
      treatment and care of the patient. Many known risk factors that contribute to SSIs include,
      but are not limited to age, nutritional status, co-morbidities, length of pre-operative stay,
      duration of operation, preoperative skin prep, and surgical techniques. In addition, there
      are certain surgical procedures in which the risks for developing SSI are greater than other
      surgical procedures. While there are various pre-operative and post-operative techniques or
      approaches to prevent these infections in patients undergoing surgeries, such as
      pre-operative skin care techniques, appropriate use of antibiotic prophylaxis, and the use of
      other post-operative anti-microbial methods, by immobilizing the patient's endogenous skin
      flora, an opportunity exists to reduce the rate of skin flora contamination which leads to
      wound contamination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Sternal Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
    <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the sternal incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Graft Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
    <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the graft incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Sternal Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
    <description>Total bacterial counts from samples of skin flora from the sternal incision site after surgery minus before surgery (prior to skin prep).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Graft Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
    <description>Total bacterial counts from samples of skin flora from the graft incision site after surgery minus before surgery (prior to skin prep).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-CABG Procedure Bacterial Count - Sternal Site</measure>
    <time_frame>Post-surgery</time_frame>
    <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the CABG procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-CABG Procedure Bacterial Count - Graft Site</measure>
    <time_frame>Post-surgery</time_frame>
    <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the CABG procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Sternal Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
    <description>Number of unique bacterial colony types isolated from samples of skin flora from the sternal incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Graft Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
    <description>Number of unique bacterial colony types isolated from samples of skin flora from the graft incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Sternal Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
    <description>Total bacterial counts from samples of skin flora from the sternal incision site immediately after incision minus before surgery (prior to skin prep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Graft Site</measure>
    <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
    <description>Total bacterial counts from samples of skin flora from the graft incision site immediately after incision minus before surgery (prior to skin prep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-incision Bacterial Count - Sternal Site</measure>
    <time_frame>Immediately after surgical incision</time_frame>
    <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the surgical incision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-incision Bacterial Count - Graft Site</measure>
    <time_frame>Immediately after surgical incision</time_frame>
    <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the surgical incision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With SSI at the Sternal Site and/or Graft Site</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients who develop at least one surgical site infection at the sternal or graft site during the 30 day post-op follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Alcohol Use, Tobacco Use, or Obesity With Surgical Site Infection (SSI)</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients with risk factors of alcohol use, tobacco use, or obesity who developed an SSI at the sternal and/or graft site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">293</enrollment>
  <condition>Skin Flora Contamination</condition>
  <arm_group>
    <arm_group_label>InteguSeal* and standard surgical preparation solutions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>InteguSeal* microbial skin sealant was applied to surgical sites prior to incision after standard surgical skin preparation in patients undergoing coronary artery bypass graft (CABG) surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard surgical skin preparation alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prior to incision, standard surgical skin preparation in patients undergoing coronary artery bypass graft (CABG) surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>InteguSeal* skin sealant and standard surgical preparation</intervention_name>
    <description>Surgical skin preparation prior to incision using InteguSeal* skin sealant following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
    <arm_group_label>InteguSeal* and standard surgical preparation solutions</arm_group_label>
    <other_name>Kimberly Clark InteguSeal* Microbial Sealant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard preoperative skin preparation</intervention_name>
    <description>Surgical skin preparation prior to incision using standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
    <arm_group_label>Standard surgical skin preparation alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for an elective Coronary Artery Bypass Graft (CABG) surgical procedure with
             median sternotomy utilizing either the saphenous vein and/or radial artery as one of
             the graft sites within 28 days of the screening date, as documented by a
             Cardiothoracic Surgeon who is the Principal Investigator or sub-investigator. This
             includes subjects who are also receiving internal mammary artery grafts in addition to
             saphenous vein and/or radial artery grafts.

          -  The skin near or around the proposed incision sites should be intact.

        Exclusion Criteria:

          -  Known sensitivity or allergy to cyanoacrylate, isopropyl alcohol, iodine or
             iodine-containing products or tape allergies.

          -  Female subjects that are nursing or actively lactating.

          -  Abnormal skin condition adjacent to or at the surgical incision sites.

          -  Hair removal at the surgical sites prior to entrance to the operating suite.

          -  Use of antimicrobial impregnated incise drapes (i.e. Ioban®).

          -  Hospital stay of &gt;14 days immediately prior to scheduled CABG surgery.

          -  Use of chemotherapy agents, within 30 days prior to Visit 1 screening.

          -  Scheduled for additional chemotherapy for the duration of the study.

          -  Known positive Human Immunodeficiency Virus (HIV) with a CD4 count &lt; 350 mm3. If HIV
             status is not known, the subject is not excluded.

          -  Currently taking antibiotics for an infection (within 30 days prior to Visit 1).

          -  Has had therapeutic radiation to the chest within 30 days of visit 1. This does not
             include subjects who receive chest xrays.

          -  Pre-operatively scheduled to have concomitant procedures with coronary artery bypass
             graft procedure.

          -  Scheduled to receive only one incision (a median sternotomy) without a planned
             saphenous vein graft and/or a radial artery graft donor site.

          -  Renal dialysis currently or within 30 days of visit 1.

          -  Morbid Obesity (Subjects with a Body Mass Index (BMI) &gt; 37).

          -  Neutropenia (absolute neutrophil count &lt;1000/mm3).

          -  Pre-operatively on an intra-aortic balloon pump or mechanical assist device.

          -  Has received an experimental drug or used an experimental medical device within 30
             days prior to Visit 1.

          -  Employees of the investigator or study center with direct involvement in the proposed
             study or other studies under the direction of that investigator or study center.

          -  Any condition, which in the opinion of the investigator would exclude the subject from
             the study.

          -  Patients on steroid use for more than 1 week within 30 days of visit 1.

          -  Patients on immunosuppressive therapy within 30 days of visit 1.

          -  Depilatory creams with containing antibiotics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charlotte D Owens, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kimberly-Clark Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wellstar Health Systems</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Institute- Dept of Thoracic Surgery</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Hernan Henriquez Aravena</name>
      <address>
        <city>Temuco</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité, Humboldt University- Department of Cardiovascular Surgery</name>
      <address>
        <city>Berlin</city>
        <zip>D-10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Heart Centre</name>
      <address>
        <city>Singapore</city>
        <zip>S168752</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Chile</country>
    <country>Germany</country>
    <country>Singapore</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dohmen PM. Influence of skin flora and preventive measures on surgical site infection during cardiac surgery. Surg Infect (Larchmt). 2006;7 Suppl 1:S13-7. Review.</citation>
    <PMID>16834542</PMID>
  </reference>
  <reference>
    <citation>Malangoni MA, Cheadle WG, Dodson TF, Dohmen PM, Jones D, Katariya K, Kolvekar S, Urban JA. New opportunities for reducing risk of surgical site infection. Roundtable discussion. Surg Infect (Larchmt). 2006;7 Suppl 1:S23-39.</citation>
    <PMID>16834544</PMID>
  </reference>
  <reference>
    <citation>Fernandez-Ayala M, Nan DN, Farinas-Alvarez C, Revuelta JM, Gonzalez-Macias J, Farinas MC. Surgical site infection during hospitalization and after discharge in patients who have undergone cardiac surgery. Infect Control Hosp Epidemiol. 2006 Jan;27(1):85-8. Epub 2006 Jan 6.</citation>
    <PMID>16418996</PMID>
  </reference>
  <reference>
    <citation>Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96.</citation>
    <PMID>10196487</PMID>
  </reference>
  <reference>
    <citation>Mertz PM, Davis SC, Cazzaniga AL, Drosou A, Eaglstein WH. Barrier and antibacterial properties of 2-octyl cyanoacrylate-derived wound treatment films. J Cutan Med Surg. 2003 Jan-Feb;7(1):1-6. Epub 2002 Oct 9.</citation>
    <PMID>12362261</PMID>
  </reference>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2007</study_first_submitted>
  <study_first_submitted_qc>April 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2007</study_first_posted>
  <results_first_submitted>November 3, 2010</results_first_submitted>
  <results_first_submitted_qc>January 17, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 11, 2011</results_first_posted>
  <last_update_submitted>September 13, 2012</last_update_submitted>
  <last_update_submitted_qc>September 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cyanoacrylates</keyword>
  <keyword>microbial sealants</keyword>
  <keyword>skin flora contamination</keyword>
  <keyword>surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled between April 2006 and February 2009 at 5 centers in the United States, Europe, Asia, and Latin America.</recruitment_details>
      <pre_assignment_details>Of 300 patients assessed for eligibility, 7 were not allocated to treatment due to inclusion or exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
        </group>
        <group group_id="P2">
          <title>Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="146"/>
                <participants group_id="P2" count="147"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
                <participants group_id="P2" count="139"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discharged from court service</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Emergency care required</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not meet inclusion/exclusion criteri</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinuation reason missing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
        </group>
        <group group_id="B2">
          <title>Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="146"/>
            <count group_id="B2" value="147"/>
            <count group_id="B3" value="293"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.18" spread="8.53"/>
                    <measurement group_id="B2" value="62.94" spread="9.97"/>
                    <measurement group_id="B3" value="63.06" spread="9.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <description>Data for n=145 microbial skin sealant, n=147 control</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.67" spread="0.10"/>
                    <measurement group_id="B2" value="1.66" spread="0.09"/>
                    <measurement group_id="B3" value="1.67" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.2" spread="14.4"/>
                    <measurement group_id="B2" value="73.8" spread="12.0"/>
                    <measurement group_id="B3" value="75.0" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>Results for n=145 microbial skin sealant, n=147 control.</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.3" spread="4.0"/>
                    <measurement group_id="B2" value="26.6" spread="3.4"/>
                    <measurement group_id="B3" value="26.9" spread="3.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obesity</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Obese (BMI&gt;30.0 kg/m^2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not obese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                    <measurement group_id="B2" value="127"/>
                    <measurement group_id="B3" value="233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus, type 1 or 2</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>present</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>absent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco Use</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alcohol Use</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Functional Classification</title>
          <description>The NYHA Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity:
Class I: No symptoms and no limitation in ordinary physical activity.
Class II: Mild symptoms and slight limitation during ordinary activity. Comfortable at rest.
Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest.
Class IV: Severe limitations. Experiences symptoms even while at rest.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Class I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Sternal Site</title>
        <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the sternal incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
        <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Sternal Site</title>
          <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the sternal incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
          <population>Per protocol</population>
          <units>isolates</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.34" spread="1.0"/>
                    <measurement group_id="O2" value="-1.31" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The sample size determination was selected to achieve 80% power to detect an absolute 10% difference between the two treatment groups in proportion of qualitative reduction in representative skin flora, at a significance level (alpha) of 0.05 using a two-sided z-test with continuity correction.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.655</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Sternal Site</title>
        <description>Total bacterial counts from samples of skin flora from the sternal incision site after surgery minus before surgery (prior to skin prep).</description>
        <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Sternal Site</title>
          <description>Total bacterial counts from samples of skin flora from the sternal incision site after surgery minus before surgery (prior to skin prep).</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.14" spread="1.4"/>
                    <measurement group_id="O2" value="-1.99" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.276</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Graft Site</title>
        <description>Total bacterial counts from samples of skin flora from the graft incision site after surgery minus before surgery (prior to skin prep).</description>
        <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bacterial Count From Pre-skin Preparation to Post-CABG - Graft Site</title>
          <description>Total bacterial counts from samples of skin flora from the graft incision site after surgery minus before surgery (prior to skin prep).</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.42" spread="1.3"/>
                    <measurement group_id="O2" value="-2.31" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.375</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-CABG Procedure Bacterial Count - Sternal Site</title>
        <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the CABG procedure.</description>
        <time_frame>Post-surgery</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-CABG Procedure Bacterial Count - Sternal Site</title>
          <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the CABG procedure.</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="1.0"/>
                    <measurement group_id="O2" value="0.83" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.039</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-CABG Procedure Bacterial Count - Graft Site</title>
        <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the CABG procedure.</description>
        <time_frame>Post-surgery</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-CABG Procedure Bacterial Count - Graft Site</title>
          <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the CABG procedure.</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.5"/>
                    <measurement group_id="O2" value="0.34" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.057</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Sternal Site</title>
        <description>Number of unique bacterial colony types isolated from samples of skin flora from the sternal incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
        <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Sternal Site</title>
          <description>Number of unique bacterial colony types isolated from samples of skin flora from the sternal incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
          <population>Per protocol</population>
          <units>isolates</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="116"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.53" spread="0.9"/>
                    <measurement group_id="O2" value="-1.59" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.646</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Graft Site</title>
        <description>Number of unique bacterial colony types isolated from samples of skin flora from the graft incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
        <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-incision - Graft Site</title>
          <description>Number of unique bacterial colony types isolated from samples of skin flora from the graft incision site immediately after the incision minus before surgery (prior to surgical skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
          <population>Per protocol</population>
          <units>isolates</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.95" spread="1.1"/>
                    <measurement group_id="O2" value="-1.98" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.788</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Sternal Site</title>
        <description>Total bacterial counts from samples of skin flora from the sternal incision site immediately after incision minus before surgery (prior to skin prep)</description>
        <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Sternal Site</title>
          <description>Total bacterial counts from samples of skin flora from the sternal incision site immediately after incision minus before surgery (prior to skin prep)</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.51" spread="1.3"/>
                    <measurement group_id="O2" value="-2.54" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.960</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Graft Site</title>
        <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the graft incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
        <time_frame>Before surgery (prior to skin preparation) and after surgery (after closing fascia)</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Unique Bacterial Isolates From Pre-skin Preparation to Post-CABG - Graft Site</title>
          <description>Number of unique bacterial colony types isolated from samples of skin flora taken from the graft incision site after surgery minus before surgery (prior to skin prep). Unique colonies were determined based on Gram stain, colony morphology, catalase, coagulase, or staphylococci latex agglutination and oxidase tests.</description>
          <population>Per protocol</population>
          <units>isolates</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.88" spread="1.1"/>
                    <measurement group_id="O2" value="-1.75" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The sample size determination was selected to achieve 80% power to detect an absolute 10% difference between the two treatment groups in proportion of qualitative reduction in representative skin flora, at a significance level (alpha) of 0.05 using a two-sided z-test with continuity correction.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.359</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Graft Site</title>
        <description>Total bacterial counts from samples of skin flora from the graft incision site immediately after incision minus before surgery (prior to skin prep)</description>
        <time_frame>Before surgery (prior to skin preparation) and immediately after incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bacterial Count From Pre-skin Preparation to Post-incision - Graft Site</title>
          <description>Total bacterial counts from samples of skin flora from the graft incision site immediately after incision minus before surgery (prior to skin prep)</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.51" spread="1.3"/>
                    <measurement group_id="O2" value="-2.58" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.730</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-incision Bacterial Count - Sternal Site</title>
        <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the surgical incision</description>
        <time_frame>Immediately after surgical incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-incision Bacterial Count - Sternal Site</title>
          <description>Total bacterial counts from samples of skin flora of the sternal incision site taken immediately following the surgical incision</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.7"/>
                    <measurement group_id="O2" value="0.26" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.348</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-incision Bacterial Count - Graft Site</title>
        <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the surgical incision</description>
        <time_frame>Immediately after surgical incision</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-incision Bacterial Count - Graft Site</title>
          <description>Total bacterial counts from samples of skin flora of the graft incision site taken immediately following the surgical incision</description>
          <population>Per protocol</population>
          <units>log CFU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.4"/>
                    <measurement group_id="O2" value="0.08" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.512</p_value>
            <method>Wilcoxon-Rank Sum Test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With SSI at the Sternal Site and/or Graft Site</title>
        <description>Number of patients who develop at least one surgical site infection at the sternal or graft site during the 30 day post-op follow-up period</description>
        <time_frame>30 days</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With SSI at the Sternal Site and/or Graft Site</title>
          <description>Number of patients who develop at least one surgical site infection at the sternal or graft site during the 30 day post-op follow-up period</description>
          <population>Intention to treat</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="146"/>
                <count group_id="O2" value="147"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.285</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Alcohol Use, Tobacco Use, or Obesity With Surgical Site Infection (SSI)</title>
        <description>Number of patients with risk factors of alcohol use, tobacco use, or obesity who developed an SSI at the sternal and/or graft site</description>
        <time_frame>30 days</time_frame>
        <population>Subset of Intention to treat participants with alcohol use, tobacco use, or obesity</population>
        <group_list>
          <group group_id="O1">
            <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
          </group>
          <group group_id="O2">
            <title>Standard Surgical Preparation Solutions</title>
            <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Alcohol Use, Tobacco Use, or Obesity With Surgical Site Infection (SSI)</title>
          <description>Number of patients with risk factors of alcohol use, tobacco use, or obesity who developed an SSI at the sternal and/or graft site</description>
          <population>Subset of Intention to treat participants with alcohol use, tobacco use, or obesity</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="112"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.024</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <desc>Investigators assessed patients for the occurrence of adverse events at each study visit and recorded in case report form. Device-related adverse events, surgical site infections, and death were the only types of adverse events collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>InteguSeal* and Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, surgical sites were prepared using InteguSeal* following standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w. InteguSeal* is a film-forming cyanoacrylate-based microbial skin sealant developed to decrease wound contamination by endogenous skin flora.</description>
        </group>
        <group group_id="E2">
          <title>Standard Surgical Preparation Solutions</title>
          <description>Prior to incision, standard surgical preparation with povidone iodine or 0.7% available iodine in isopropyl alcohol 74% w/w.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.5</frequency_threshold>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous graft site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Skin graft infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>All publications and presentations resulting from this multi-center trial sponsored by Kimberly-Clark must be approved by all investigators and the sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Shu-Ping Yang</name_or_title>
      <organization>Kimberly-Clark Health Care</organization>
      <phone>770-587-7267</phone>
      <email>Shu-Ping.Yang@kcc.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

